Cargando…
Tiotropium in asthma: back to the future of anticholinergic treatment
Asthma is among the most common chronic diseases worldwide; however, despite progresses in the understanding of the patho-physiological mechanisms and advances in the development of new therapeutic options and strategies, the disease remains uncontrolled in a not trivial proportion of subjects. Thus...
Autores principales: | Bonini, Matteo, Scichilone, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713051/ https://www.ncbi.nlm.nih.gov/pubmed/29213218 http://dx.doi.org/10.1186/s12948-017-0076-1 |
Ejemplares similares
-
Future perspectives of anticholinergics for the treatment of asthma in adults and children
por: Buhl, Roland, et al.
Publicado: (2019) -
The evolving role of tiotropium in asthma
por: McIvor, Emma R, et al.
Publicado: (2017) -
Safety of tiotropium in patients with asthma
por: Dusser, Daniel, et al.
Publicado: (2019) -
Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives
por: Chari, V. Madhu, et al.
Publicado: (2018) -
The role of tiotropium in the management of asthma
por: Park, Heung-Woo
Publicado: (2012)